Upregulation and coexpression of adhesion molecules correlate with relapsing autoimmune demyelination in the central nervous system by unknown
T
he mechanisms by which circulating immune cells recog-
nize a target organ are not well understood, but in the
case of the central nervous system (CNS), where the blood
brain barrier (BBB) prevents free interchange between blood
and CNS parenchyma, such mechanisms are probably fun-
damental to inflammation . In diseases of the CNS like mul-
tiple sclerosis (MS) and its laboratory model, experimental
autoimmune encephalomyelitis (EAE), initiating events are
believed to involve changes at theBBB resulting in increased
vascular permeability. These events may facilitate the adhe-
sion of lymphocytes to CNS endothelium, after which cells
invade the target organ and initiateT cell-mediated demyeli-
nation (1) . Similar molecular events occur in lymph nodes,
where, at the sites of lymphocyte extravasation, blood vessels
have endothelial cells (EC) of a distinct cuboidal morphology :
high endothelial venules (HEV) (2). In rheumatoid arthritis,
EC acquire properties ofHEV at sites of lymphocyte adhe-
sion and invasion (3) . In adoptively transferred EAE, EC have
been described withHEV morphology to which mononuclear
cells were attached during lesion formation (4, 5) . The present
study has examined within theCNS during chronic relapsing
adoptively transferred EAE, the expression oftwo molecules
associated with cell adhesion: MECA-325, a murine HEV
marker (6) ; andMALA2, the murine homologue ofhuman
intercellular adhesion molecule 1 (ICAM-1) (7, 8) .
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Summary
The expression of adhesion molecules on central nervous system (CNS) vessels was examined
during chronic relapsing experimental autoimmune encephalomyelitis in the SJL mouse. Two
molecules associated with cell adhesion were studied : MECA325, a murine lymph node high
endothelial venule marker; andMALA2, the murine homologue of intercellular adhesion molecule
1. During initial disease, upregulated coexpression of these two molecules occurred in the CNS .
This correlated with inflammatory cell invasion . During remission, expression was downregulated,
and each subsequent relapse was accompanied by corresponding upregulation. Thus, up- and
downregulation of adhesion molecules in the target organ appeared to form an integral part
ofthe inflammatory process in thisautoimmune condition and support a role for receptor-mediated
inflammatory cell invasion of relevance to the pathogenesis of multiple sclerosis .
Animals and Immunization.
￿
Female SJL/J mice (The Jackson
Laboratory, Bar Harbor, ME), 6-8 wks of age, were maintained
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in an NIH/AAALAC approved facility. Donor SJL/J mice were
immunized with guinea pig myelin basic protein (MBP) for the
transfer of MBP-sensitized lymphocytes into naive, syngeneic
recipients (9), and were sampled during the pre-clinical (24- 48 h
before onset ofsigns), acute, remitting, and relapsing stages. Animals
first showed signs ofEAE 6-8 d post-transfer (PT) .
Tissue Processing and Immunocytochemistry .
￿
Frozen sections (10
jam) of CNS tissue were fixed in acetone for 10 min and stained
with the avidin-biotin-peroxidase complex (ABC) technique and
3',3-diaminobenzidine as the chromagen . As controls, kidney and
lymph node tissues were studied. Incubations were performed over-
night with the rat monoclonals MECA325 (6), used at a 1:10 di-
lution ; YNI/1, which detectsMALA2 (7, 8), used as straight su-
pernate ; anti-lymphocyte function-associated antigen (LFA-1)
(Boehringer-Mannheim Biochemicals, Indianapolis, IN), used at
1:20; biotinylated la' (from MKS-4 hybridoma) (American Type
Culture Collection, Rockville, MD), purified by affinity chroma-
tography, used at 1:25; and anti-L3T4 (Becton Dickinson& Co.,
Mountain View, CA), used at 1:100. Control sections were incubated
with PBS. For double labeling, rabbit anti-glial fibrillary acidic pro-
tein (GFAP) antibody, (gift of J.E. Goldman, Columbia Univer-
sity), was used at 1:100.
Results
Spinal cord sections reacted for MECA-325 showed that
during the preclinical phase, thisHEV marker was expressed
at low levels on the surface of EC . It was not seen in the
CNS ofnormal mice. MECA325 expression was greatly up-
regulated on the majority of postcapillary venules in spinal
cord white matter lesions during the acute phase within 24-
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tory cell invasion was prominent (Fig. 1 a) . Unaffected white
matter, grey matter, and rostral CNS regions showed no
MECA-325 reactivity . MECA-325 decreased during clinical
remissions to near preclinical levels (Fig. 1 b), and then in-
creased markedly again during each relapse (Fig. 1 c) . Differ-
ences in MECA-325 staining between preclinical and acute
stages, and between relapses and remissions, were statistically
significant (Fig . 2) .
Low levels ofICAM-1 were noted in the spinal cord during
the preclinical phase, similar to MECA-325 . ICAM-1 was
greatly upregulated in lesion areas during the acute phase (Fig .
1 d), tapering off during remission (Fig. 1 e) . ICAM-1 ex-
pression subsequently increased with each relapse (Fig. 1 f),
Figure 1 .
￿
Sections of spinal cord tissue from mice with chronic relapsing EAE demonstrate fluctuations in expression ofadhesion molecules, MECA-
325 and MALA-2 (ICAM-1), coincident with clinical activity. Upregulated expression of MECA-325 is seen on the surface ofEC during the acute
phase ofadoptively transferred EAE (a) ; this decreases during clinical remission (b), and increases again during relapse (c) . The same fluctuating pattern
is shown for MALA-2 expression during acute disease (d), remissions (e), and relapses (f) . In e, note the lack of expression along the majority of
the vessels, the small area to the right which is MALA-2* , and the positively staining astrocytes (armws) . a-f (x550).
1522
￿
Adhesion Molecule Expression during DemyelinationFigure 2 .
￿
A histogram illustrates the up- and downregulation of adhe-
sion molecules in theCNS of mice with adoptively transferred EAE cor-
relating with clinical activity. Expression of MECA-325, MALA-2, and
LFA-1 was significantly different when the preclinical vs. acute stage, and
relapses vs . remissions were compared. MECA-325, p < 0.002 and p <
0.05; MALA-2, p < 0.05 and p < 0.01 ; LFA-1, p < 0.05 and p < 0.01,
respectively . Differences in la expression were significant only for preclin-
ical vs. acute stages (p < 0.05), and in CD4 expression, for relapses vs.
remissions (p < 0.05) . The score was based on the density of positive
immunoperoxidase-labeled cells as determined by two blinded observers.
Frozen sections from 15 animals were analyzed . Numerical values (0-4)
were assigned corresponding to the percentage scale, and significance was
determined by the student's t test .
and was found on EC of all vessels, perivascular cells, and
scattered astrocytes (Fig . 1 e), which were also GFAP+ . Un-
like MECA-325, low levels were seen on EC and glial cells
in the CNS ofnormal mice. Statistical comparison ofICAM-1
at various stages of disease revealed the differences to be
significant (Fig . 2) .
Infiltration of the CNS correlated with clinical onset, as
has been demonstrated previously (9) . The majority of the
infiltrating cells were LFA1' . LFA1 expression also closely
paralleled that of its ligand, ICAM-1, and of MECA-325
(Fig. 2) .
Class 11 MHC molecules, also implicated in adhesion (10,
11) were expressed during the acute and relapsing phases,
similar to MECA325 and ICAM-1 (Fig. 2) . MHC class II
expression occurred on perivascular cells ; CNS EC appeared
to be MHC class II negative . T cells expressing CD4, the
ligand forMHC class II, were first demonstrated in the CNS
during the preclinical stage and increased during the acute
and relapsing phases . During remissions, CD4' cells de-
creased in number. To test whether the fluctuation in adhe-
sion molecule expression was target organ specific, kidney
sections from each group (preclinical, acute, remission, and
relapse) were tested forMECA325, ICAM-1, andMHC class
11, and were uniformly negative. As a positive control, lymph
node tissue was routinely included and was always positive
for MECA-325, ICAM-1, LFA1, MHC class II, and CD4 .
Discussion
The coexpression of two distinct adhesion-associated mol-
ecules not normally seen in CNS tissue has been shown within
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theCNS ofmice with relapsing autoimmune demyelination.
One ofthese, MECA325, is normally present only in lymph
node tissue, and the other, ICAM-1, while most common
in hematopoietic tissue, is seen at low levels in several organs,
including the CNS (12) . Our study has shown a close corre-
lation of disease activity with adhesion molecule expression.
Since understanding of the mechanisms in the trafficking of
immune cells to CNS white matter might be fundamental
to the inflammatory demyelinating diseases, we compared the
expression of a number of adhesion-related molecules within
the CNS at different stages of chronic relapsing EAE .
The appearance ofMECA-325 occurred at the'BBB and
paralleled lymphocytic infiltration . To our knowledge, this
represents the first demonstration of an HEV determinant
at CNS inflammatory sites . Whether the selective induction
of this HEV molecule preceded or occurred during lympho-
cyte extravasation is not yet clear . The data suggest that the
differentiation ofHEVlike vessels was a gradual process oc-
curring simultaneously with increasing lymphocytic influx .
The present results support the concept ofcell traffic being
associated with the modulation of expression of HEV mole-
cules on target organ vessels. The reasons for these fluctua-
tions remain speculative but may relate to cytokines elabo-
rated locally. For example, interferon y, a product of activated
T cells, isknown to induce MECA-325, ICAM-1, andMHC
class II on a variety ofcells, including EC (6, 13, 14) . Previous
studies using 14C-labeled T cell blasts to induce adoptively
transferred EAE showed that some MBP-immune cells ar-
rived at the CNS vasculature 24-48 h before clinical onset
(4) . The arrival of radiolabeled cells appeared to precede un-
labeled cells, suggesting that the original CNS-immune cells
induced local changes at the BBB, which then precipitated
the influx ofCNS antigen-nonspecific cells (4, 5) . These events
may have morphologic correlates in that by ultrastructure,
HEVlike vessels with unique membrane specializations oc-
curred in the CNS during early EAE (5) .
MECA-325 is a member of the addressin family, a group
of molecules whose apparent role is to signal and direct cell-
to-cell interactions. Its ligand is unknown . With regard to
function, MECA325 antibodies do not inhibit lymphocyte
binding, thus not supporting its direct role in cell adhesion
(15) . MECA-325 may define a distinct epitope on HEV in-
volved in some other aspect of lymphocyte/endothelial cell
interactions (15) . The inappropriate presence of HEVlike
vessels in the CNS, coupled with the fluctuations ofMECA
325 with disease activity, appear to implicate this molecule
in EAE . Parallel studies using an antibody against a constitu-
tive antigen, von Willebrandt Factor (vWF), confirmed that
the MECA-325 reactivity was specific .
Cell adhesion is an essential component of the response
ofT lymphocytes to antigens. Our demonstration ofincreased
ICAM-1 in the CNS, particularly on EC, is the first to sup-
port a role for ICAM-1 during inflammation and demyelina-
tion in EAE . ICAM-1 is a member of the Ig gene super-
family and has been associated with activated lymphocytes
and sites of inflammation (13) . The present fluctuations in
ICAM-1 expression and its receptor LFA1 (16, 17), on inflam-
matory cells, suggest this interaction may play a role in themediationoflymphocytic traffic intoCNSinflammatory sites .
This speculation is supported by a recent study showing
ICAM-1 in human MS and control CNS lesions (12) .
The expression ofMECA325, ICAM-1, andMHC class
II appears to be importantin leukocytehoming and adhesion
to the BBB during active stages ofautoimmune demyelina-
tion . Their fluctuating patterns ofexpression corresponding
to periods of clinical worsening support a functional role .
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